SLNO R&D Expenses

Soleno Therapeutics Inc · R&D Expenses

SLNO logo

SLNO R&D Expenses

Latest reported$38.38M
SLNO R&D Expenses ($2.47M → $38.38M)
High-resolution chart · PNG

SLNO r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Soleno Therapeutics Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
40,627,000
78,568,000
25,189,000
15,265,000
21,453,000
23,191,000
16,267,000
7,178,000
3,068,742
5,184,803
4,536,244
2,242,216
2,379,832
2,469,913
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.